PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Leaf hexane extract fractions showed antiproliferative capacity (IC50 of 24 ± 9 μg/mL in HCT 116 cells) and antimutagenic activity against sodium azide in strain TA100 [PMID:33397268].
Extract showed antioxidant and anti-tyrosinase activities and inhibited the production of IL-1alpha, TNF-alpha, and alpha-MSH in UV-stimulated human epidermal melanocytes [PMID:19000188].
Evidence summary
PubMed sources
- 1.PMID: 33397268 (2021) — Antimutagenic, Antiproliferative and Antioxidant Properties of Sea Grape Leaf Extract Fractions (Coccoloba uvifera L.). · Anti-cancer agents in medicinal chemistry
- 2.PMID: 29535364 (2018) — A pantropically introduced tree is followed by specific ectomycorrhizal symbionts due to pseudo-vertical transmission. · The ISME journal
- 3.PMID: 38795268 (2024) — Mexican Coccoloba uvifera L. Leaf and Fruit Extracts: Identification of Pentacyclic Triterpenes and Volatile Profile by GC-MS. · Plant foods for human nutrition (Dordrecht, Netherlands)
- 4.PMID: 30042552 (2018) — Use of emerging technologies in the extraction of lupeol, α-amyrin and β-amyrin from sea grape (Coccoloba uvifera L.). · Journal of food science and technology
- 5.PMID: 39367926